Oncology A history of blood cancer treatment Despite being one of the most common forms of cancer, awareness of blood cancer pales in comparison to other types of the disease.
Oncology Servier’s ASCO 2025 Data: Advancing IDH-Mutated Cancer Treat... At ASCO 2025, Servier’s Becky Martin discusses IDH-mutated cancers, including key insights on Tibsovo & Voranigo, and the implications for patients.
